Andrew Grulich
Andrew Grulich is a prominent HIV researcher affiliated with the Kirby Institute in Australia, known for his work in epidemiology and public health. His research focuses on the prevention and treatment of HIV, contributing to significant advancements in the field, including studies on the effectiveness and accessibility of antiretroviral medications. Grulich has been vocal about the need for affordable HIV treatments, emphasizing the importance of making innovative drugs like lenacapavir accessible to populations at risk.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Brazil | 1 | 3.00 | 0.07% | +0% | 211,049,527 | 152,163 | $1,500,000 | 1,081$ |
| Totals | 1 | 211,049,527 | 152,163 | $1,500,000 | 1,081$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
Andrew Grulich is a professor at the Kirby Institute for HIV research who criticized the high cost of lenacapavir.
3